➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKinsey
Express Scripts
Moodys
Harvard Business School

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089406


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 089406 describes POLOCAINE-MPF, which is a drug marketed by Fresenius Kabi Usa and is included in three NDAs. It is available from two suppliers. Additional details are available on the POLOCAINE-MPF profile page.

The generic ingredient in POLOCAINE-MPF is mepivacaine hydrochloride. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.
Summary for 089406
Tradename:POLOCAINE-MPF
Applicant:Fresenius Kabi Usa
Ingredient:mepivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 089406
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for 089406
Suppliers and Packaging for NDA: 089406
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POLOCAINE-MPF mepivacaine hydrochloride INJECTABLE;INJECTION 089406 ANDA HF Acquisition Co LLC, DBA HealthFirst 51662-1403 51662-1403-1 30 mL in 1 VIAL, SINGLE-DOSE (51662-1403-1)
POLOCAINE-MPF mepivacaine hydrochloride INJECTABLE;INJECTION 089406 ANDA Fresenius Kabi USA, LLC 63323-260 63323-260-37 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-260-37) > 30 mL in 1 VIAL, SINGLE-DOSE (63323-260-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1%
Approval Date:Dec 1, 1986TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Baxter
AstraZeneca
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.